University of Colorado Anschutz Medical Campus
Aurora, Colorado, 80232, United States
Location contact
Matthew Griffith, MD
SUB_INVESTIGATOR
Rachel Johnson, PhD, LCSW
CONTACT
NCT Number: NCT06770777
Narrative-based tiered asynchronous psychosocial and behavioral whole health support for people adjusting to living with COPD. The intervention is administered by experienced LCSWs under the PI's supervision.
Trial opening soon.
Get Notified18 year–89 year
All sexes
Interventional
Not applicable
Aurora, Colorado, 80232, United States
Matthew Griffith, MD
SUB_INVESTIGATOR
Rachel Johnson, PhD, LCSW
CONTACT
This study will advance health access equity for people with Chronic Obstructive Pulmonary Disease (COPD) by providing an asynchronous, patient-led, web-based, adaptive, flexible, and tiered intervention that easily integrates into the daily lives of both providers and patients living with COPD. This intervention includes health navigation education, health and behavior coaching, and narrative, strengths-based mental and behavioral health support. COPD is a complex chronic illness with multiple domains to study whole person support. Not only because of the significant impact of a lack of whole person support for people living with COPD but also because COPD shares many of the same symptomology and impact on daily living as other significant chronic illnesses such as heart failure, some neurological disorders, and some types of cancer (5-7). The lessons learned from studying COPD whole person support can be applied to other similar symptomatic burdensome chronic illnesses that also suffer from fragmented care.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The website design allows study participants to choose the intervention tier(s) that meets their needs. There are three tiers from Tier 1: Information only, Tier 2 Reflective Writing, and Tier 3 LCSW Psychotherapeutic Intervention. Participants will also be able to choose multiple tiers if they are interested in continuing their participation. First Tier: The website offers standardized information about COPD care, healthcare navigation, and whole-person care. Information includes symptom management, disease progression and trajectory, healthcare navigation concepts, and directs people to the VA website with information about whole-person care. Second Tier: If participants choose, they can also select writing prompts with opportunities to reflect on their whole-person care and adjustment to illness. Third Tier: People living with COPD can also select to have asynchronous interaction with a licensed clinical social worker providing the narrative-based psychotherapeutic intervention.
Other names: Reflective writing prompts, Psychotherapy, Healthcare navigation and coaching
Time frame: 0 months, 3 months
The PHQ9 is a standardized, validated measurement used to track depression in both clinical and research settings.
Time frame: 0 months, 3 months
The GAD7 is an established, validated measurement of anxiety in clinical and research settings.
Time frame: 0 months, 3 months
The SGRQ is an established and validated respiratory distress measurement for people with COPD in both clinical and research settings.
Contact information is provided by the study sponsor or research team.
University of Colorado, Denver
Other
Development And Evaluation of An Adaptive Web-Based Intervention for Whole Health Support For Patients With Chronic Pulmonology Obstructive Disease (COPD)
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07719192
COPD (Chronic Obstructive Pulmonary Disease), Chronic Disease
Lahore, Punjab Province, Pakistan
View Trial DetailsNCT07713043
COPD (Chronic Obstructive Pulmonary Disease), Chronic Disease
Lahore, Punjab Province, Pakistan
View Trial DetailsNCT07703527
COPD (Chronic Obstructive Pulmonary Disease), Chronic Disease
Omaha, Nebraska, United States
View Trial DetailsNCT07612878
COPD (Chronic Obstructive Pulmonary Disease), Chronic Disease
View Trial Details